Delisting risk
INVO Fertility (IVF)
Operates fertility clinics and sells INVOcell for intravaginal culture.
$1.03
Pre-market+0.03 (+3.00%)
At close$1.00(−0.99%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions6 holders · as of Mar 31, 2026 | 10.75% | 192.1K shares | |
| Insiders1 holder · as of Jan 13, 2026 | 0.00% | 0 shares | |
| Strategic holders1 holder · as of Apr 1, 2026 | 7.53% | 134.5K shares | |
| Otherremainder | 81.72% | 1.46M shares |
1.79M company shares as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
The share count has not been confirmed by a second filing; stakes use it as it stands.
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
Institutions13F, as of Mar 31, 2026
6 holders · 192.1K shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Mariner, LLC | 100.0K | 5.60% | May 13, 2026 | |
| Armistice Capital, LLC | 71.9K | 4.02% | May 15, 2026 | |
| Geode Capital Management, LLC | 16.8K | 0.94% | May 15, 2026 | |
| UBS Group AG | 3.3K | 0.19% | May 5, 2026 | |
| Citigroup Inc | 15 | 0.00% | May 11, 2026 | |
| Sbi Securities Co., Ltd. | 3 | 0.00% | Apr 28, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Five Narrow Lane LP | 9.99% | 13G | Jan 15, 2025 ↗ | |
| Glenbrook Capital Management | 8.33% | 134.5K | 13G | Apr 1, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Dec 3, 2025 | Matthew K. Szotdirector | Sale | 4 | $1.52 | 3 |
CongressHouse and Senate disclosures
Not reported.
